Last reviewed · How we verify

NCT06244381

Indirect Calorimetry Versus Urea-creatinine Ratio to Evaluate Catabolism in Critically Ill Patients

Completed Last updated 19 February 2025
What this trial tests

trial in Critically Ill in 20 participants. Completed in 1 October 2024.

Timeline
1 March 2024
Primary endpoint
30 June 2024
1 October 2024

Quick facts

Lead sponsorHospital Sao Domingos
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date1 March 2024
Primary completion30 June 2024
Estimated completion1 October 2024
Sites1 location across Brazil

Conditions studied

Sponsor

Hospital Sao Domingos

Who can join

18 and older, any sex, with Critically Ill. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the efficiency of the urea/creatinine ratio as a catabolism marker compared to indirect calorimetry to optimize nutritional support in critically ill patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Critically Ill

Currently open trials in the same condition.

Other Hospital Sao Domingos trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06244381.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing